Skip to main content
older man reading on ipad

TREATING

CENTRAL SLEEP APNEA

Media Kit

About the remedē® System

The remedē System is a breakthrough implantable system that safely and effectively treats moderate to severe Central Sleep Apnea (CSA) in adult patients. CSA is a serious breathing disorder that disrupts the normal breathing pattern during sleep and has been shown to negatively impact quality of life and heart health.1

In a clinical study, the remedē System has been shown to improve sleep, oxygen levels and enhance overall quality of life:

  • 87% of patients had a reduction in Apnea-Hypopnea Index, an indication of CSA severity2,3
  • 79% of patients had an improvement in quality of life2,4
  • 91% of patients were free from serious adverse events related to the implant procedure, the device, or delivered therapy at 12 months2
Media Contact

Collin Anderson
Vice President of Marketing
952-540-4474
canderson1@zoll.com

The remedē® System Clinical Trial News Releases